Home »
Academic Articles & Research Papers
Showing 20 of 21 academic articles
Zhang L, Gao Y, Wang X, Gu Y et al. • Frontiers in immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fimmu.2026.1942041
PMC: PMC13728784
Teppala S, Koo J, Tan ECK, Clarke S et al. • International journal of clinical pharmacy
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1007/s11096-026-02202-3
PMC: PMC13731505
Ziemska-Legięcka J, Żeber-Lubecka N, Borucka M, Kaczmarska D et al. • Frontiers in immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fimmu.2026.1972440
PMC: PMC13733417
Zhong Y, Wang J, Chen B, Xu Y et al. • Cancer immunology, immunotherapy : CII
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1007/s00262-026-04516-7
PMC: PMC13737224
Shang F, Zhang Y, Zhou Q, Zhu M et al. • Frontiers in immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fimmu.2026.1982129
PMC: PMC13735926
Wang Z, Yang K, Wang L, Zhao H et al. • Frontiers in pharmacology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fphar.2026.1861637
PMC: PMC13541713
Pan C, Zhang R, Niu Y, Zhang W et al. • Translational cancer research
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.21037/tcr-2026-1-0328
PMC: PMC13559675
Delgado Leon F, de Armas SA, Molina M, Morales EG et al. • International journal of molecular sciences
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3390/ijms27177849
PMC: PMC13566543
Lai H, Sun K, Mu T, Liu X et al. • Oncology reports
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3892/or.2026.9202
PMC: PMC13646777
Chung S, Liu H, Khan M, Patel TS et al. • medRxiv : the preprint server for health sciences
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.64898/2026.07.27.26359037
PMC: PMC13484339
Linping Hui, Siyang Zhang, Muli Wudu, Hongjiu Ren et al. • Thoracic Cancer
(2019)
Background Studies have shown that E3 ubiquitin ligase CBLL1 plays multiple roles in development and tumorigenesis. CBLL1 is over‐expressed in colon cancer and associated with cancer cell proliferation. While, the overexpression of CBLL1 in...
DOAJ
Open Access (DOAJ)
DOI: 10.1111/1759-7714.13097
Heabin Kim, Hyun-Taek Kim, Seung-Hyun Jung, Jong Won Han et al. • Marine Drugs
(2023)
The discovery of new highly effective anticancer drugs with few side effects is a challenge for drug development research. Natural or synthetic anticancer peptides (ACPs) represent a new generation of anticancer agents with high selectivity...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/md21120607
Lilla Bűdi, Dániel Hammer, Rita Varga, Veronika Müller et al. • Pathology and Oncology Research
(2025)
ObjectivesSpingosine-1-phosphate (S1P) and ceramides are bioactive sphingolipids that influence cancer cell fate. Anti-ceramide antibodies might inhibit the effects of ceramide. The aim of this study was to assess the potential role of circ...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/pore.2024.1611929
W.M. Szejniuk, M.S. Nielsen, D. Brønnum, Z. Takács-Szabó et al. • Clinical and Translational Radiation Oncology
(2019)
Introduction: The aim of the study was to investigate repetitive fractional exhaled nitric oxide (FeNO) measurements during high-dose radiation therapy (HDRT) and to evaluate the use of FeNO to predict symptomatic radiation pneumonitis (RP)...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.ctro.2019.09.004
Patrick Leo, Hauke Kolster, Hartmut Koeppen, Jennifer Giltnane et al. • Journal of Pathology Informatics
(2026)
Whereas anti-PD-(L)1 therapies are widely used in cancer treatment, only a subset of patients achieve long-term survival. Companion diagnostics based on PD-L1 expression have limited predictive power for these therapies, motivating developm...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.jpi.2026.100688
Sophia Daum, Lilith Decristoforo, Mira Mousa, Stefan Salcher et al. • Molecular Cancer
(2025)
Abstract The dynamic interactions between tumor endothelial cells (TECs) and the immune microenvironment play a critical role in the progression of non-small cell lung cancer (NSCLC). In general, endothelial cells exhibit diverse immunomodu...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12943-024-02221-6
Song X, Chen D, Yuan M, Wang H et al. • Cancer Management and Research
(2021)
Song X, Chen D, Yuan M, Wang H, Wang Z. Cancer Manag. 2018;10:6677– 6683On page 6677, Abstract, Results subheading, the median baseline PLR should be 136.1.On page 6680, Results section, 2nd paragraph, the median baseli...
DOAJ
Open Access (DOAJ)
Demi Brownlie, Andreas von Kries, Giampiero Valenzano, Nicole Wild et al. • OncoImmunology
(2023)
Lung cancer is a leading cause of cancer-related death worldwide. Despite recent advances in tissue immunology, little is known about the spatial distribution of tissue-resident lymphocyte subsets in lung tumors. Using high-parameter flow c...
DOAJ
Open Access (DOAJ)
DOI: 10.1080/2162402X.2023.2233402
Angel Chao, Ren-Chin Wu, Chiao-Yun Lin, Ting-Chang Chang et al. • Biomedical Journal
(2023)
Small cell neuroendocrine carcinoma of the cervix (SCNECC) is an uncommon but aggressive uterine malignancy, the cause of which is generally associated with human papillomavirus (HPV) infection. A lack of clinical trials and evidence-based ...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.bj.2023.100633
Leander van Eekelen, Joey Spronck, Monika Looijen-Salamon, Shoko Vos et al. • Scientific Reports
(2024)
Abstract Programmed death-ligand 1 (PD-L1) expression is currently used in the clinic to assess eligibility for immune-checkpoint inhibitors via the tumor proportion score (TPS), but its efficacy is limited by high interobserver variability...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41598-024-57067-1